Author

L. Fiori

Observed name: L Fiori

Institutions: Mayo Clinic, Precision Therapeutics (United States), UPMC Health System, Mayo Clinic in Florida, The University of Texas Southwestern Medical Center

Observed institutions: Mayo Clinic, Precision Therapeutics (United States), UPMC Health System, Mayo Clinic in Florida, The University of Texas Southwestern Medical Center

OpenAlex ID: A5079049330

Deoxycytidine and deoxythymidine kinase activities in plasma of mice and patients with neoplastic disease.

1982 · W Kreis, Z Arlin, et al. · PubMed · 20

An ex vivo chemoresponse assay predicts carboplatin-induced progression-free interval in ovarian cancer

2004 · R. Coleman, T. Herzog, et al. · Journal of Clinical Oncology · 1

Ex vivo chemoresponse assay of ovarian cancers predicts clinical outcome

2004 · H. Gallion, W. Christopherson, et al. · Journal of Clinical Oncology

Works count: 3

Citation count: 21

H-index: 1

I10-index: 1